The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of NTRK1 gene fusion incidence in an unselected cohort of non-small cell lung cancer patients.
Robert Charles Doebele
Consultant or Advisory Role - Boehringer Ingelheim; Pfizer
Research Funding - Mirati Therapeutics
Other Remuneration - NTRK1 Patent
Severine Kako
No relevant relationships to disclose
Anh T. Le
Other Remuneration - NTRK1 Patent
Marcos da Costa Silva
No relevant relationships to disclose
Aria Vaishnavi
No relevant relationships to disclose
Luca Toschi
No relevant relationships to disclose
Armando Santoro
No relevant relationships to disclose
Massimo Roncalli
No relevant relationships to disclose
Dara Aisner
Consultant or Advisory Role - Boehringer Ingelheim
Honoraria - Abbott Molecular; Illumina
Marileila Varella-Garcia
Other Remuneration - NTRK1 Patent